Short Interest in Lexaria Bioscience Corp. (NASDAQ:LEXXW) Expands By 41.7%

Lexaria Bioscience Corp. (NASDAQ:LEXXW) was the target of a large increase in short interest in October. As of October 15th, there was short interest totalling 5,100 shares, an increase of 41.7% from the September 30th total of 3,600 shares. Based on an average trading volume of 14,200 shares, the days-to-cover ratio is presently 0.4 days.

Lexaria Bioscience Price Performance

LEXXW stock traded down $0.03 during mid-day trading on Tuesday, reaching $0.85. 300 shares of the company traded hands, compared to its average volume of 15,426. The firm’s 50 day moving average price is $0.99 and its 200 day moving average price is $1.10. Lexaria Bioscience has a fifty-two week low of $0.12 and a fifty-two week high of $2.50.

Lexaria Bioscience Company Profile

Lexaria Bioscience Corp. operates as a biotechnology company. It develops and out-licenses its patented drug delivery technology, DehydraTECH, which combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods.